Press Release – New York, NY – September 8, 2026 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, in its $5.9 Million warrant inducement transaction.
H.C. Wainwright & Co. acted as the exclusive placement agent for the transaction.
The SRFC team was led by partners Gregory Sichenzia and Avital Perlman, with associate Benasz Hansotia.